Back to search

Article

Comparative Study of BBB-Targeting AAV Capsids on Central Nervous System Delivery Efficiency

2026-02-04

Abstract excerpt

<title>Abstract</title> <p> The efficacy of adeno-associated virus (AAV)-mediated systemic gene therapy for central nervous system (CNS) diseases is often limited by the blood-brain barrier (BBB). This study systematically evaluated the tissue distribution of three BBB-crossing AAV capsid variants (PHP.eB, CNSRCV300, and BI-hTFR1) following intravenous injection in mice, using either a constitutive promoter (CAG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16181cbd-b11e-5eb5-89c4-9827b6908703
DOI
10.21203/rs.3.rs-8716281/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Study of BBB-Targeting AAV Capsids on Central Nervous System Delivery EfficiencyDOI 10.21203/rs.3.rs-8716281/v1
Select a neighboring publication to make it the new centre.